The case involves a company petition filed by M/s. Vance & Health Pharmaceuticals Private Limited (Operational Creditor) against M/s. Therdose Pharma Private Limited (Corporate Debtor) under Section 9 of the Insolvency and Bankruptcy Code, 2016. The Operational Creditor and Corporate Debtor entered into an agreement titled "All India Super Distribution and Consultation Agreement" on 13-03-2017, with an effective date of 01-03-2017. The Corporate Debtor was appointed as the Super Distributor & Consultant, with exclusive rights to operate the Operational Creditor's domestic business in India, Nepal, and Sri Lanka for three years (01-03-2017 to 28-02-2019). The Corporate Debtor agreed to purchase products from the Operational Creditor at an agreed price
…M/s. Vance & Health Pharmaceuticals Private Limited (Operational Creditor) filed a company petition against M/s. Therdose Pharma Private Limited (Corporate Debtor) under Section 9 of the Insolvency and Bankruptcy Code, 2016. The Operational Creditor and Corporate Debtor entered into an "All India Super Distribution and Consultation Agreement" on 13-03-2017, effective from 01-03-2017, where the Corporate Debtor was appointed as the Super Distributor & Consultant for India, Nepal, and Sri Lanka for three years. The Corporate Debtor agreed to purchase products from the Operational Creditor for exclusive distribution. The Operational Creditor supplied pharmaceutical products worth Rs. 2,00,98,835 between 10-03-2017 and 17-11-2017, but the Corporate Debtor
…Sign in to view the parties.
Effective date of the "All India Super…
Date of the "All India Super Distribution and…
The case involves a company petition filed by M/s. Vance & Health Pharmaceuticals Private Limited (Operational Creditor) against M/s. Therdose Pharma Private Limited (Corporate Debtor) under Section 9 of the Insolvency and Bankruptcy Code, 2016. The Operational Creditor and Corporate Debtor entered into an agreement titled "All India Super Distribution and Consultation Agreement" on 13-03-2017, with an effective date of 01-03-2017. The Corporate Debtor was appointed as the Super Distributor & Consultant, with exclusive rights to operate the Operational Creditor's domestic business in India, Nepal, and Sri Lanka for three years (01-03-2017 to 28-02-2019). The Corporate Debtor agreed to purchase products from the Operational Creditor at an agreed price
…M/s. Vance & Health Pharmaceuticals Private Limited (Operational Creditor) filed a company petition against M/s. Therdose Pharma Private Limited (Corporate Debtor) under Section 9 of the Insolvency and Bankruptcy Code, 2016. The Operational Creditor and Corporate Debtor entered into an "All India Super Distribution and Consultation Agreement" on 13-03-2017, effective from 01-03-2017, where the Corporate Debtor was appointed as the Super Distributor & Consultant for India, Nepal, and Sri Lanka for three years. The Corporate Debtor agreed to purchase products from the Operational Creditor for exclusive distribution. The Operational Creditor supplied pharmaceutical products worth Rs. 2,00,98,835 between 10-03-2017 and 17-11-2017, but the Corporate Debtor
…Effective date of the "All India Super…
Date of the "All India Super Distribution and…